These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 193079)

  • 21. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin].
    Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
    Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
    Hendricks RL; Janowicz M; Tumpey TM
    J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
    Chrisp CE; Sunstrum JC; Averill DR; Levine M; Glorioso JC
    Lab Invest; 1989 Jun; 60(6):822-30. PubMed ID: 2543866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific viral antigens in rat cells transformed by herpes simplex virus type 2 and in rat tumors induced by inoculation of transformed cells.
    Macnab JC; Visser L; Jamieson AT; Hay J
    Cancer Res; 1980 Jun; 40(6):2074-9. PubMed ID: 6245808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro malignant transformation of hamster retina by herpes simplex virus.
    Albert DM; Papale JJ; Strumph P; Fournier GA
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1489-95. PubMed ID: 6315628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valacyclovir treatment ameliorates the persistently increased pentylenetetrazol-induced seizure susceptibility in mice with herpes simplex virus type 1 infection.
    Wu HM; Liang YC; Chen SH; Huang CC; Chen SH; Tsai JJ; Hsieh CL; Hsu KS
    Exp Neurol; 2004 Sep; 189(1):66-77. PubMed ID: 15296837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
    Drescher KM; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion.
    Brust D; Feden J; Farnsworth J; Amir C; Broaddus WC; Valerie K
    Cancer Gene Ther; 2000 May; 7(5):778-88. PubMed ID: 10830725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrinsic resistance to viral infection. Mouse macrophage restriction of herpes simplex virus replication.
    Sarmiento M
    J Immunol; 1988 Oct; 141(8):2740-8. PubMed ID: 2844905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of newborn murine retinal cells to herpes simplex virus type 1 infection.
    Merges MJ; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1224-30. PubMed ID: 2163995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical carcinogenesis with herpes simplex virus, type 2.
    Wentz WB; Reagan JW; Heggie AD
    Obstet Gynecol; 1975 Aug; 46(2):117-21. PubMed ID: 168521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modelling of viral-chemical carcinogenesis in chronic infection in mice caused by the herpes simplex type 2 virus].
    Kitsak VIa; Moĭsiadi SA; Bocharov AF
    Vopr Virusol; 1979; (3):277-82. PubMed ID: 462927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice.
    Thomas EE; Lau AS; Kim SU; Osborne D; Kastrukoff LF
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2051-7. PubMed ID: 1654369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of Lewis lung carcinoma by the concomitant infection of the host with herpes simplex virus type 1 and type 2.
    Reiss-Gutfreund RJ; Dostal V; Nowotny NR
    Oncology; 1983; 40(1):46-51. PubMed ID: 6296746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.